| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Dr. James A. HelliwellCEO & Director | 150.00k | 83.43k | Derivative Exercise and Retained Stock | 0.56 | 1.06M | 16.57% |
| 2026-03-09 | Dr. Richard M. GlickmanIndependent Director | -3.13k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-27 | Dr. Simon N. PimstoneIndependent Chairman | 12.00k | 81.82k | 買い | 6.77 - 6.88 | 48.68k | 32.72% |
| 2026-03-27 | Dr. James A. HelliwellCEO & Director | 30.00k | 64.88k | Derivative Exercise and Retained Stock | 2.16 | 905.01k | 3.43% |
| 2026-03-18 | Mr. Joseph S. FreedmanIndependent Director | 18.70k | 145.85k | 買い | 7.42 - 7.97 | 2.54M | 0.74% |
| 2026-03-18 | PNG Enterprise Foundation法人 | -15.00k | 85.45k | Derivative Exercise and Sale | 2.19 - 7.89 | 33.73k | - |
| 2026-03-18 | PNG Enterprise Foundation法人 | 33.73k | 73.89k | Derivative Exercise and Retained Stock | 2.19 | 33.73k | - |
| 2026-03-16 | Mr. Paul L. GeyerIndependent Director | -48.73k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-08 | Dr. Richard M. GlickmanIndependent Director | -3.13k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-09 | Mr. Paul L. GeyerIndependent Director | -12.50k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-09 | Mr. John Salvatore MontalbanoIndependent Director | -21.88k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-09 | Dr. Michael WilminkIndependent Director | -1.53k | 0.00 | Other Derivative Disposition | - | 0.00 | -100.00% |
| 2026-03-02 | Mr. Joseph S. FreedmanIndependent Director | 170.00k | 371.93k | Derivative Exercise and Retained Stock | 2.19 | 2.52M | 7.22% |
| 2026-02-20 | Mr. Joseph S. FreedmanIndependent Director | 280.00k | 1.96M | 買い | 7.00 | 2.35M | 13.50% |
| 2026-02-02 | Mr. John Salvatore MontalbanoIndependent Director | 243.90k | 534.87k | Derivative Exercise and Retained Stock | 2.19 | 1.54M | 18.87% |
| 2026-01-23 | Mr. Alexander John RothwellCFO | 104.00k | 227.19k | Derivative Exercise and Retained Stock | 2.18 | 1.10M | 10.40% |
| 2026-01-23 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 5.00k | 40.78k | Derivative Exercise and Retained Stock | 8.16 | 48.50k | 11.49% |
| 2025-12-15 | Dr. Richard M. GlickmanIndependent Director | 20.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | 6.27 | 260.00k | 8.33% |
| 2025-12-15 | Mr. Alexander John RothwellCFO | 231.25k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 446.25k | 107.56% |
| 2025-12-15 | Dr. Amanda MaloneChief Scientific Officer & COO | 285.50k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 861.00k | 49.61% |
| 2025-12-15 | Dr. Simon N. PimstoneIndependent Chairman | 20.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 302.50k | 7.08% |
| 2025-12-15 | Mr. Paul L. GeyerIndependent Director | 20.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 238.75k | 9.14% |
| 2025-12-15 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 80.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 340.00k | 30.77% |
| 2025-12-15 | Mr. John Salvatore MontalbanoIndependent Director | 20.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 246.25k | 8.84% |
| 2025-12-15 | Dr. Mark M. Kowalskiインサイダー | 85.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 395.00k | 27.42% |
| 2025-12-15 | Dr. Michael WilminkIndependent Director | 20.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 222.50k | 9.88% |
| 2025-11-24 | Mr. Paul Anthony BrennanChief Corporate Development Officer | 16.30k | 101.92k | 買い | 6.23 - 6.30 | 43.50k | 59.93% |
| 2025-11-15 | Dr. Simon N. PimstoneIndependent Chairman | 25.00k | 142.65k | Derivative Exercise and Retained Stock | 5.71 | 36.68k | 214.08% |
| 2025-11-14 | Mr. John Salvatore MontalbanoIndependent Director | 12.50k | 71.32k | Derivative Exercise and Retained Stock | 5.71 | 1.29M | 0.98% |
| 2025-11-02 | Dr. Simon N. PimstoneIndependent Chairman | -25.00k | 0.00 | Other Derivative Disposition | - | 282.50k | -8.13% |
| 2025-11-02 | Mr. Paul L. GeyerIndependent Director | -12.50k | 0.00 | Other Derivative Disposition | - | 218.75k | -5.41% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100.50k | 53.32k | Derivative Exercise and Retained Stock | 0.53 | 875.01k | 12.98% |
| 2025-11-02 | Mr. John Salvatore MontalbanoIndependent Director | -12.50k | 0.00 | Other Derivative Disposition | - | 226.25k | -5.24% |
| 2025-11-02 | Dr. Amanda MaloneChief Scientific Officer & COO | -3.75k | 0.00 | Other Derivative Disposition | - | 575.50k | -0.65% |
| 2025-11-06 | Dr. James A. HelliwellCEO & Director | 100.50k | 35.43k | Derivative Exercise and Retained Stock | 0.35 | 875.01k | 12.98% |
| 2025-11-02 | Dr. James A. HelliwellCEO & Director | -18.75k | 0.00 | Other Derivative Disposition | - | 1.28M | -1.45% |
| 2025-11-02 | Dr. Michael WilminkIndependent Director | -12.50k | 0.00 | Other Derivative Disposition | - | 202.50k | -5.81% |
| 2025-09-23 | Dr. Richard M. GlickmanIndependent Director | 4.93k | 27.12k | 買い | 5.50 | 18.86k | 35.39% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -1.50k | 0.00 | Other Disposition | - | 2.07M | -0.07% |
| 2025-09-26 | Mr. Joseph S. FreedmanIndependent Director | -3.50k | 0.00 | Other Disposition | - | 2.07M | -0.17% |
| 2025-09-24 | Dr. Simon N. PimstoneIndependent Chairman | 3.05k | 16.79k | 買い | 5.50 | 11.68k | 35.38% |
| 2025-09-24 | Mr. Joseph S. FreedmanIndependent Director | 240.79k | 1.32M | 買い | 5.50 | 2.08M | 13.11% |
| 2025-09-24 | Mr. John Salvatore MontalbanoIndependent Director | 67.27k | 370.00k | 買い | 5.50 | 1.28M | 5.55% |
| 2025-09-24 | Dr. Michael WilminkIndependent Director | 3.36k | 18.50k | 買い | 5.50 | 228.23k | 1.50% |
| 2025-05-13 | Dr. Simon N. PimstoneIndependent Chairman | 43.75k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 307.50k | 16.59% |
| 2025-05-13 | Mr. Paul L. GeyerIndependent Director | 25.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 231.25k | 12.12% |
| 2025-05-13 | Mr. John Salvatore MontalbanoIndependent Director | 25.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 238.75k | 11.70% |
| 2025-05-13 | Dr. Amanda MaloneChief Scientific Officer & COO | 12.50k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 579.25k | 2.21% |
| 2025-05-13 | Dr. James A. HelliwellCEO & Director | 50.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 1.29M | 4.02% |
| 2025-05-13 | Dr. Michael WilminkIndependent Director | 25.00k | 0.00 | Derivative Acquisition Under Employee Benefit Plan | - | 215.00k | 13.16% |
| 2025-06-16 | Mr. Joseph S. FreedmanIndependent Director | 33.40k | 134.95k | 買い | 3.89 - 4.34 | 1.53M | 2.22% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。